Syphilis RPR vs Treponemal Test Explained

Syphilis testing uses two different kinds of blood tests. An RPR is a nontreponemal test that measures the body's reaction to tissue damage and can be tracked as a titer, while a treponemal test detects antibodies aimed directly at the syphilis bacterium. A diagnosis needs both steps to agree.

The bottom-line difference

An RPR (rapid plasma reagin) doesn't look for the syphilis germ at all. It detects antibodies your body makes against fatty material released when cells are damaged by infection, a non-specific signal that rises and falls with disease activity. A treponemal test detects antibodies that specifically target Treponema pallidum, the bacterium that causes syphilis. Because each test answers a different question, syphilis is diagnosed with a two-step algorithm: one test screens, the other confirms, and a result isn't final until the confirmatory step agrees CDC, 2024.

What each test actually is

The nontreponemal test (RPR or VDRL)

The RPR and its close cousin the VDRL are nontreponemal tests. They measure reagin antibodies, your immune response to lipid material from damaged cells, and they're reported as a titer, the highest dilution of your blood that still reacts (for example, 1:8 or 1:32). That number climbs with active, untreated infection and falls after successful treatment, so clinicians use it to track whether therapy is working. But it isn't specific. Pregnancy, other infections, and autoimmune conditions can trigger a false-positive reagin signal, so an RPR alone can never confirm syphilis.

The treponemal test (TP-PA, FTA-ABS, or EIA/CIA)

Treponemal tests detect antibodies aimed directly at the syphilis bacterium. Names you'll see on a lab report include TP-PA, FTA-ABS, and the automated EIA/CIA immunoassays many labs now run first. These are highly specific, so a positive strongly points to a true treponemal infection at some point in life. Their limitation is the mirror image of the RPR's: once positive, most people stay treponemal-positive for life, even after a fully treated infection. A treponemal test can confirm exposure but can't tell a current infection from one cured years ago, and it can't be tracked as a titer to gauge treatment response.

The key differences, one at a time

What they detect

RPR detects an indirect, non-specific immune reaction to cellular damage. The treponemal test detects antibodies specific to T. pallidum. One is a smoke detector; the other identifies the fire.

Whether the number means anything

The RPR gives a titer that rises and falls, a number a clinician watches over time. A fourfold drop after treatment (say 1:32 down to 1:8) signals success; a fourfold rise suggests new infection or treatment failure. Treponemal tests are usually reported simply as reactive or nonreactive, with no useful titer to follow.

How long they stay positive

An RPR generally normalizes, often becoming nonreactive, after the infection is cured, which makes it useful for monitoring. A treponemal test typically stays positive for life regardless of treatment, so it can't distinguish past from present disease.

Their failure modes

RPR's weakness is false positives from unrelated conditions, plus a possible prozone effect where extremely high antibody levels paradoxically blunt the reaction unless the lab dilutes the sample. The treponemal test's weakness is that it can't confirm an infection is active or current.

RPR vs treponemal: side by side

Which test applies to you, and how to choose

In practice, you usually don't choose. The lab runs an algorithm that pairs the two. There are two standard sequences. The traditional algorithm screens with an RPR first; if reactive, a treponemal test confirms. The reverse-sequence algorithm, common in larger labs running automated immunoassays, screens with a treponemal EIA/CIA first; if reactive, an RPR follows to gauge activity, and a second, different treponemal test resolves any disagreement between the first two.

This is also why a single test result can be confusing on its own. A positive treponemal screen with a nonreactive RPR may mean an old, treated infection rather than a new one, which is why the second test exists. The same two-step logic protects against false alarms in HIV and syphilis alike: an initial screen, then a different confirmatory test, with nothing final until they agree CDC HIV testing.

When to test after exposure: the window period

Syphilis has a slow onset, and the antibody tests can be nonreactive during the earliest infection. The primary sore, called a chancre, typically appears about three weeks after exposure (incubation runs roughly 10 to 90 days), and antibodies may take up to two more weeks after that sore shows up before a blood test turns positive StatPearls, Syphilis. A test done very soon after a risky encounter can miss a real infection.

A negative test after a recent exposure does not clear you. Retest after the window passes rather than relying on that first result. For the timing logic across different infections, see our guide on when to test after exposure. This window explains many missed cases, though the biology covered next matters more.

Who should get screened

Screening recommendations come from the U.S. Preventive Services Task Force, and two carry its strongest Grade A rating:

• All pregnant people: universal, early screening regardless of risk. If someone wasn't screened early, they should be tested at the first opportunity, even at delivery USPSTF, Pregnancy.
• Nonpregnant adolescents and adults at increased risk: including men who have sex with men, people with HIV or another STI, anyone with a history of incarceration or sex work, and people in higher-prevalence communities USPSTF, 2022.

These recommendations track a real and worsening trend. Primary and secondary syphilis reached about 53,000 reported cases in 2023, and the late or unknown-duration stage roughly doubled, from about 26 to nearly 30 per 100,000, between 2020 and 2023 CDC AtlasPlus, 2023. It's also unevenly spread: South Dakota, Washington DC, New Mexico, and Mississippi posted the highest primary-and-secondary rates, several times the national average. Congenital syphilis nearly doubled in four years, from 2,163 cases in 2020 to 3,882 in 2023, a 77% rise and the highest level in decades. Untreated syphilis in pregnancy damages the baby in 50 to 80% of cases through stillbirth, prematurity, newborn death, or congenital infection. Prenatal screening plus penicillin stops nearly all of it. For the full clinical picture, read syphilis overview.

The practical next step

Syphilis testing is a quick blood draw, minutes in the chair, with results back in a day or a few. You don't order RPR versus treponemal yourself; you ask to be screened for syphilis, and the lab applies the algorithm. If you want to schedule that, here's how to get tested, and you're rarely far from a clinic: the US has some 15,000 federally funded community health center sites and about 4,200 Title X family-planning clinics, most offering free or sliding-scale care HRSA health centers. Planned Parenthood and local health departments do the same.

Timing matters as much as the test choice. Syphilis antibodies take time to appear, so a test run too soon after a possible exposure can read negative even when infection is present. The test isn't wrong; the antibodies just aren't detectable yet. If you tested early, plan to repeat it; here's a guide to when to test after exposure and a broader look at when and why to retest for stds.

If your result is positive

Syphilis is curable, and penicillin G given by injection is the preferred drug at every stage; the schedule depends on how long you've been infected. For the full regimen, doses, and what the shots are like, see our guide to syphilis treatment CDC STI Treatment Guidelines.

When to talk to a clinician

Bring any reactive syphilis result to a clinician rather than trying to interpret it alone. The meaning depends on your titer, which algorithm the lab used, your treatment history, and your symptoms. See someone promptly if you notice a painless sore, an unexplained rash (including on the palms or soles), or if a partner tests positive. Syphilis is cured with the right antibiotic course, and a clinician will use the RPR titer to confirm the treatment worked. Treat any new vision change or neurological symptom, confusion, severe headache, weakness, hearing loss, as an emergency: syphilis can invade the eyes or nervous system at any stage, so ocular syphilis and neurosyphilis are not only late-stage problems. Having syphilis also roughly doubles the risk of acquiring HIV.

For the named-test pairing specifically, see RPR vs FTA-ABS.

Keep exploring on EasySTD: compare testing services, confidential testing by state and Syphilis testing.